DelveInsight’s “Prostate Cancer Pipeline Insight” report provides comprehensive insights about key companies and pipeline drugs in the Prostate Cancer Market pipeline landscapes.
The report comprises Prostate Cancer pipeline drug profiles, including clinical and non-clinical stage products. It also includes the Prostate Cancer Market therapeutics assessment by product type, stage, route of administration, and molecule type and further highlights the inactive Prostate Cancer Market pipeline products.
Prostate Cancer Overview
Prostate cancer is a type of malignancy that occurs in the prostate gland, which is a part of the male reproductive system. Prostate cancer is the 3rdmost prevalent type of cancer in the US and the fourth most common worldwide. In the majority of the cases, the symptoms of prostate cancer are not apparent in the early stages of the disease. Due to the proximity of the prostate gland to the bladder and urethra, prostate cancer may be accompanied by a variety of urinary symptoms, especially in the early stages. Depending on its size and location, a tumor may press on and constrict the urethra, inhibiting the flow of urine. Furthermore, Prostate cancer may metastasize and form tumors in nearby organs or bones. If cancer spreads to the spine, it may press on the spinal nerves. Symptoms of Prostate Cancer often differ from patient to patient.
Some of the key takeaways from the Prostate Cancer Pipeline Report:
Companies across the globe are diligently working toward the development of novel treatment therapies with a considerable amount of success over the years. Key players, such as AstraZeneca/Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene or Candel Therapeutics, Merck Sharp & Dohme, etc., are developing therapies for the treatment of Prostate Cancer Market.
Emerging therapies such as Lynparza, Opdiv, Lutathera, Relugolix, Niraparib, HC-1119, Ipatasertib, Talazoparib, Rucaparib, ProstAtak, Keytruda, are expected to have a significant impact on the Prostate Cancer Market market in the coming years.
Get an overview of pipeline landscape @ Prostate Cancer Clinical Trials Analysis
Prostate Cancer Pipeline Therapies along with Key Players:
Lynparza: AstraZeneca/Merck Sharp & Dohme
Opdivo: Bristol-Myers Squibb
Lutathera: Novartis
Relugolix: Myovant Sciences
Niraparib: Janssen Research & Development
HC-1119: Hinova Pharmaceuticals USA
Ipatasertib: Hoffmann-La Roche
Talazoparib: Pfizer/Astellas Pharma
Rucaparib :Clovis Oncology
ProstAtak : Advantagene or Candel Therapeutics
Keytruda :Merck Sharp & Dohme, and others
Scope of Prostate Cancer Pipeline Drug Insight
Coverage: Global
Major Players: AstraZeneca/Merck Sharp & Dohme, Bristol-Myers Squibb, Novartis, Myovant Sciences, Janssen Research & Development, Hinova Pharmaceuticals USA, Hoffmann-La Roche, Pfizer/Astellas Pharma, Clovis Oncology, Advantagene or Candel Therapeutics, Merck Sharp & Dohme, and others.
Pipeline Therapies: Lynparza, Opdiv, Lutathera, Relugolix, Niraparib, HC-1119, Ipatasertib, Talazoparib, Rucaparib, ProstAtak, Keytruda, and others.
Table of Contents
1
Prostate Cancer Market Report Introduction
2
Prostate Cancer Market Executive Summary
3
Prostate Cancer Market Overview
4
Prostate Cancer Market- Analytical Perspective In-depth Commercial Assessment
5
Prostate Cancer Market Pipeline Therapeutics
6
Prostate Cancer Market Late Stage Products (Phase II/III)
7
Prostate Cancer Market Mid Stage Products (Phase II)
8
Prostate Cancer Market Early Stage Products (Phase I)
9
Prostate Cancer Market Preclinical Stage Products
10
Prostate Cancer Market Therapeutics Assessment
11
Prostate Cancer Market Inactive Products
12
Company-University Collaborations (Licensing/Partnering) Analysis
13
Prostate Cancer Market Key Companies
14
Prostate Cancer Market Key Products
15
Prostate Cancer Market Unmet Needs
16
Prostate Cancer Market Market Drivers and Barriers
17
Prostate Cancer Market Future Perspectives and Conclusion
18
Prostate Cancer Market Analyst Views
19
Appendix
20
About DelveInsight
Get a customized pipeline report @ Prostate Cancer Drugs Pipeline Report
Related Reports:
Prostate Cancer Market
DelveInsight’s ‘Prostate Cancer Market-Market Insights, Epidemiology, and Market Forecast—2030’ report delivers an in-depth understanding of the 7MM, historical and forecasted epidemiology as well as the 7MM market trends in the United States, EU5 (Germany, France, Italy, Spain, and United Kingdom),
Prostate Cancer Epidemiology
DelveInsight’s ‘Prostate Cancer Market Epidemiology Forecast to 2030′ report delivers an in-depth understanding of the disease, historical and forecasted Cholangiocarcinoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/